Office-Based Treatment of Opioid Dependence

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Office-Based Treatment of Opioid Dependence"

Transcription

1 Office-Based Treatment of Opioid Dependence Saturday, November 5, :30 PM to 5:30 PM Mason General Hospital, Shelton, Washington PROGRAM OVERVIEW Washington State is currently facing an epidemic of addiction and deaths related to the use of prescription opioids. This course aims to helps physicians and their clinical teams improve their care of pain and addiction. In 2010, Washington State passed HB 2876, requiring physicians to have 4 hours of education on long acting opioids. This course will satisfy the requirement. The Drug Addiction Treatment Act of 2000 permits physicians who are trained or experienced in opioid addiction treatment to obtain waivers to prescribe certain narcotic drugs in Schedule III, IV or V of the Controlled Substances Act, in their office practices or in a clinic setting, for the treatment of opioid dependence. Both buprenorphine and the combination of buprenorphine with naloxone are approved by the FDA for use in detoxification and maintenance treatment of opioid dependence. This course combines DVD and face-to-face training to meet the requirement for training needed to obtain the waiver to prescribe buprenorphine in office-based treatment of opioid dependence. A DVD will be sent to physicians who register, containing 4 hours of training and an exam. Proof of successful completion of the exam must be printed and brought to the course as part of the process to obtain a waiver for prescribing buprenorphine. The materials will also be posted on Click on Training to access forms and presentations to complete prior to the training. Clinicians should bring the completed forms with them Nov 5 th. WHO SHOULD ATTEND? This program is intended for physicians, medical residents and health sciences medical, pharmacy and nursing faculty. Mid-level providers ARNPs and other non-physician professionals are not eligible for the waiver, but along with other partners in the practice including nurses and counselors or practice managers are strongly encouraged on a space available basis. Attendance is limited to 40. PROGRAM GOALS After attending this session participants will be able to: Describe prerequisites for a physician to begin to prescribe buprenorphine in office-based practice. Discuss clinically relevant pharmacological characteristics of buprenorphine. Identify appropriate patients for office-based treatment of opioid addiction. Describe induction and maintenance protocols. Discuss strategies for integrating psychosocial care with office-based pharmacological treatment. Discuss the management of chronic and acute pain in patients on treatment for opioid dependence. Discuss the Risk Evaluation and Mitigation strategies for buprenorphine use. 1

2 Planning Committee: Roger A. Rosenblatt, MD, MPH, MFR, Professor and Vice Chair, UW Department of Family Medicine RUOP Director - UW School of Medicine, Seattle, WA. Diane Yu, MD, MSPH- Thurston-Mason County Health Officer Cole Mason, MD- President of Thurston-Mason Medical Society Susan Peterson, Executive Director, Thurston-Mason County Medical Society Joseph O. Merrill MD, MPH - Clinical Assistant Professor of Medicine, Attending Physician, Harborview Medical Center, Seattle, WA. Mary Catlin BSN, MPH - Continuing Education Specialist IV, Project Roam, Department of Family Medicine, Seattle, WA. Constance Hirnle MN, RN, BC - Senior Lecturer, Department of Biobehavioral Nursing and Health Systems, UW School of Nursing, Seattle, WA. COMPLETING THE REQUEST FOR A DEA WAIVER Physicians who complete this course will receive the certificate of attendance needed to send to the Secretary of HHS along with the request for the waiver. With your permission, AOAAM/AAAP will report your name directly to the Secretary of HHS within 4 weeks of the program thus eliminating the need for you to send the certificate of attendance. During the course you will have an opportunity to fill out and mail your waiver request. The form will ask you to provide the DEA number of all physicians in the practice who will be prescribing Buprenorphine for opioid addiction and your solo or group practice Tax ID employer identification number. CONTINUING EDUCATION CREDITS CME: This program is approved for 4.0 AOA Category 1-A CME credit hours, pending approval by the AOA CCME. It is also approved for 4.0 AAFP Prescribed Credit hours, which are eligible for the AMA s Physician Recognition Award Credit. CME credits are being provided by SAMSHA funding and are included in the registration fee. Nurses and Nurse Practitioners: contact hours will be available to nurses and other health care professionals.the UW School of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center s Commission on Accreditation. The UW School of Nursing is an approved clock hour provider by the Washington State Board of Education. Provider is approved by the California Board of Registered Nursing, Provider # Psychologists: The UW School of Nursing qualifies as a Washington State CE program sponsor under WA (1). Social Workers, Counselors and Other Disciplines: The UW school of Nursing qualifies as a Washington State CE Program sponsor under WAC (1). For other disciplines, a certificate will be awarded documenting attendance at this offering co-provided by the UW School of Nursing. 2

3 Faculty: Roger A. Rosenblatt MD, MPH, MFR Course Director Professor and Vice Chair, UW Department of Family Medicine RUOP Director - UW School of Medicine Joseph O. Merrill MD, MPH Clinical Assistant Professor of Medicine, Attending Physician, Harborview Medical Center L. Paul Gianutsos MD, MPH Associate Director Swedish Family Medicine Residency Cherry Hill Clinical Associate Professor of Family Medicine University of Washington David J. Tauben MD Clinical Associate Professor, Medicine Medical Director UW Center for Pain Relief, Anesthesia and Pain Medicine Director, Medical Student Education in Pain Medicine Registration: register by ing Mary Catlin that you are interested in attending the course at She will send you a confirmation of admission. CNE will be offered to nurses who attend the entire session, complete the evaluation and the exam, and send in a request to UW CNE for hours. Contact for questions. CO-PROVIDER Mason and Thurston County Health Departments, University of Washington School of Nursing, Continuing Nursing Education SPONSORS University of Washington (UW) School of Medicine Thurston-Mason County Medical Society, Mason General Hospital American Osteopathic Academy of Addiction Medicine (AOAAM) Life Sciences Discovery Fund, and the Substance Abuse and Mental Health Services Administration Grant 1H79T The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention 3

4 of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Agenda Buprenorphine in the Office-Based Treatment of Opioid Dependence ( Half and Half Course ) November 5, Mountain View Drive Shelton, WA Roger Rosenblatt MD, MPH, MFr, Course Director 12:30 PM Registration (Sign-in, complete DEA waiver, turn in baseline test, and surveys) 1:00-1:10 PM Welcome and Introduction Rosenblatt 1:10-2:00 PM Opioid Dependence Treatment with Buprenorphine/Naloxone Merrill 2:00-2:45 PM Preventing Addiction through Appropriate Pain Management and Managing Pain in Opioid Addicted Patients Tauben 2:45-3:15 PM Patient Evaluation -- Gianutsos 3:00-3:15 PM Break 3:15-4:30 PM Clinical Use of Buprenorphine in Family Practice and Overview of Clinical Tools Gianutsos 4:30-5:15 PM Case studies -- Rosenblatt 5:15-5:45 PM Exam, Sign Out CME SPONSORS University of Washington (UW) School of Medicine American Osteopathic Academy of Addiction Medicine Life Sciences Discovery Fund, the Robert Woods Johnson Foundation and the Substance Abuse and Mental Health Services Administration Grant 1H79T The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government 4

5 5

6 6

Motivational Interviewing: Quick and Effective Tools for Clinicians

Motivational Interviewing: Quick and Effective Tools for Clinicians Motivational Interviewing: Quick and Effective Tools for Clinicians November 6-7, 2012 Seattle, WA Co-provided by: Training Xchange University of Washington Center for Commercialization Department of Psychiatry

More information

Ohio Legislative Service Commission

Ohio Legislative Service Commission Ohio Legislative Service Commission Bill Analysis Brian D. Malachowsky H.B. 378 130th General Assembly () Reps. Smith and Sprague BILL SUMMARY Prohibits a physician from prescribing or personally furnishing

More information

SCOPE of Pain: Safe and Competent Opioid Prescribing Education

SCOPE of Pain: Safe and Competent Opioid Prescribing Education SCOPE of Pain: Safe and Competent Opioid Prescribing Education Disclosure of Support Our program is funded by an independent educational grant awarded by the manufacturers of extended-release (ER) and

More information

Office-based Treatment of Opioid Dependence with Buprenorphine

Office-based Treatment of Opioid Dependence with Buprenorphine Office-based Treatment of Opioid Dependence with Buprenorphine David A. Fiellin, M.D Professor of Medicine, Investigative Medicine and Public Health Yale University School of Medicine Dr. Fiellin s Disclosures

More information

Washington State Cardiac & Stroke Conference

Washington State Cardiac & Stroke Conference American Heart Association/American Stroke Association Western States Affiliate Washington State Cardiac & Stroke Conference June 9, 2015 8:00AM-12:00PM June 10, 2015 8:00AM-4:30PM Monterey/Phoenix Conference

More information

The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section

The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section TITLE I: PREVENTION SUBTITLE A- PRESCRIBER EDUCATION PRACTITIONER EDUCATION This subtitle requires practitioners who

More information

Section 303(g)(2)(G) of the Controlled Substances Act (21 U.S.C. 823(g)(2)(G)) is amended. (1) by striking clause (ii) and inserting the following:

Section 303(g)(2)(G) of the Controlled Substances Act (21 U.S.C. 823(g)(2)(G)) is amended. (1) by striking clause (ii) and inserting the following: Section XX. Definitions. Section 303(g)(2)(G) of the Controlled Substances Act (21 U.S.C. 823(g)(2)(G)) is amended (1) by striking clause (ii) and inserting the following: (ii) The term qualifying practitioner

More information

Peer Assistance and Opioid Dependency. Disclosures

Peer Assistance and Opioid Dependency. Disclosures Peer Assistance and Opioid Dependency Suzanne Kinkle, RN, BS, CARN Director - Recovery and Monitoring Program (RAMP) New Jersey State Nurses Association Al Rundio PhD, DNP, RN, APRN, NEA-BC, DPNAP Associate

More information

American Society of Addiction Medicine

American Society of Addiction Medicine American Society of Addiction Medicine Public Policy Statement on Treatment for Alcohol and Other Drug Addiction 1 I. General Definitions of Addiction Treatment Addiction Treatment is the use of any planned,

More information

Buprenorphine Policy Update: What s new with DATA 2000?

Buprenorphine Policy Update: What s new with DATA 2000? Buprenorphine Policy Update: What s new with DATA 2000? Susanne Fogger, DNP, PMHNP-BC, CARN-AP, AP, FAANP University of Alabama at Birmingham, Birmingham Alabama Katherine S. Fornili, MPH, RN, CARN University

More information

Summer Seminar in Health Care Ethics

Summer Seminar in Health Care Ethics 27th Annual Summer Seminar in Health Care Ethics August 4-8, 2014 University of Washington Campus Health Sciences Building T-747 Seattle, WA Sponsored by the University of Washington School of Medicine

More information

Neurotoxin and Headache Update

Neurotoxin and Headache Update Neurological Center for Pain in joint sponsorship with the Ohio Headache Association and Ohio Neurotoxin Association Present Neurotoxin and Headache Update October 11-12, 2013 Neurotoxin and Headache Update

More information

Veterans Health Administration Employee Education System. And. VACO Office of Quality and Safety, Evidenced Based Practice And

Veterans Health Administration Employee Education System. And. VACO Office of Quality and Safety, Evidenced Based Practice And Veterans Health Administration Employee Education System And VACO Office of Quality and Safety, Evidenced Based Practice And Department of Defense TRICARE Management Activity And U.S. Army Medical Command,

More information

OCTOBER 5-9, 2015 FEB 22-26, 2016 APRIL 25-29, 2016

OCTOBER 5-9, 2015 FEB 22-26, 2016 APRIL 25-29, 2016 Rutgers Tobacco Dependence Program in collaboration with the Center for Tobacco Surveillance and Evaluation Research and the Division of Addiction Psychiatry And co provided with Rutgers University Behavioral

More information

Recommendations and Next Steps: Reform Health Care Practice

Recommendations and Next Steps: Reform Health Care Practice Incorporate into routine medical practice screening and intervention for risky substance use and diagnosis, treatment and disease management for addiction Develop core competencies for physicians in understanding

More information

PRS 101 FOUNDATIONS OF PHARMACY REGULATION PRS 101.3: THE DRUG ENFORCEMENT ADMINISTRATION REGULATORY ROLE DR. BRUSHWOOD S MONOGRAPH

PRS 101 FOUNDATIONS OF PHARMACY REGULATION PRS 101.3: THE DRUG ENFORCEMENT ADMINISTRATION REGULATORY ROLE DR. BRUSHWOOD S MONOGRAPH PRS 101 FOUNDATIONS OF PHARMACY REGULATION PRS 101.3: THE DRUG ENFORCEMENT ADMINISTRATION REGULATORY ROLE DR. BRUSHWOOD S MONOGRAPH PRS 101.3 THE DRUG ENFORCEMENT ADMINISTRATION REGULATORY ROLE ACTIVITY

More information

Program Assistance Letter

Program Assistance Letter Program Assistance Letter DOCUMENT NUMBER: 2004-01 DATE: December 5, 2003 DOCUMENT TITLE: Use of Buprenorphine in Health Center Substance Abuse Treatment Programs TO: All Bureau of Primary Health Care

More information

MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS

MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS David Gaugh, R.Ph. Senior Vice President for Sciences and Regulatory

More information

Published by Waterford Life Sciences, Washington, DC 202-299-0600 Cover and book design: Gretchen Maxwell, GLM Design

Published by Waterford Life Sciences, Washington, DC 202-299-0600 Cover and book design: Gretchen Maxwell, GLM Design Copyright 2007 Scott M. Fishman, MD CME Activity Copyright 2009 The University of Wisconsin Board of Regents Published by Waterford Life Sciences, Washington, DC 202-299-0600 Cover and book design: Gretchen

More information

American Indian Health Commission for Washington State October 1, 2015

American Indian Health Commission for Washington State October 1, 2015 American Indian Health Commission for Washington State October 1, 2015 States with more opioid pain reliever sales tend to have more drug overdose deaths Death rate, 2011, National Vital Statistics System.

More information

Fundamentals of Addiction Medicine Conference

Fundamentals of Addiction Medicine Conference 16th Annual Fundamentals of Addiction Medicine Conference jointly sponsored by March 13-14, 2014 Tulalip Resort & Spa Marysville, Washington Faculty Daniel P. Alford, MD, MPH, ACP, FASAM Associate Professor

More information

National Perspectives in Medication Assisted Treatment

National Perspectives in Medication Assisted Treatment National Perspectives in Medication Assisted Treatment Addiction Medicine Asheville March 21,2014 Melinda Campopiano, MD Medical Officer Substance Abuse & Mental Health Services Administration Guten Appetit

More information

Medical & Health Symposium

Medical & Health Symposium Ohio Workers Compensation Medical & Health Symposium Tracks Pain and Neuromusculoskeletal Management FREE Continuing Education March 10 11, 2016 Greater Columbus Convention Center 400 N. High St., Columbus,

More information

Opioid Treatment Services, Office-Based Opioid Treatment

Opioid Treatment Services, Office-Based Opioid Treatment Optum 1 By United Behavioral Health U.S. Behavioral Health Plan, California Doing Business as OptumHealth Behavioral Solutions of California ( OHBS-CA ) 2015 Level of Care Guidelines Opioid Treatment Services,

More information

UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths

UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths Joanna G Katzman, M.D., M.S.P.H Director, UNM Pain Center Associate Professor,

More information

TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION

TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION The Tennessee Board of Medical Examiners has reviewed the Model Policy Guidelines for Opioid Addiction Treatment

More information

RE: Medication Assisted Treatment for Opioid Use Disorders RIN 0930-AA22

RE: Medication Assisted Treatment for Opioid Use Disorders RIN 0930-AA22 May 31, 2016 Substance Abuse and Mental Health Services Administration Department of Health and Human Services ATTN: Jinhee Lee, SAMHSA 5600 Fishers Lane Room 13E21C Rockville, MD 20857 RE: Medication

More information

Using Buprenorphine in an Opioid Treatment Program

Using Buprenorphine in an Opioid Treatment Program Using Buprenorphine in an Opioid Treatment Program Thomas E. Freese, PhD Director of Training, UCLA Integrated Substance Abuse Programs Director, Pacific Southwest Addiction Technology Transfer Center

More information

Care Management Council submission date: August 2013. Contact Information

Care Management Council submission date: August 2013. Contact Information Clinical Practice Approval Form Clinical Practice Title: Acute use of Buprenorphine for the Treatment of Opioid Dependence and Detoxification Type of Review: New Clinical Practice Revisions of Existing

More information

Albany Medical College presents. Saturday, May 2, 2015 7:30 AM 4:30 PM

Albany Medical College presents. Saturday, May 2, 2015 7:30 AM 4:30 PM Albany Medical College presents AMC Pulmonary and Symposium Saturday, May 2, 2015 7:30 AM 4:30 PM Hudson Valley Community College Bulmer Telecommunications Center 80 Vandenburgh Ave. Troy, New York Sponsored

More information

aspectsofasthma conference march 7 2015 corpus christi texas

aspectsofasthma conference march 7 2015 corpus christi texas aspectsofasthma conference march 7 2015 corpus christi texas purpose and goal This half day seminar is designed to provide health care professionals with an in-depth knowledge of asthmatic disorders, including

More information

Patient access to medical records

Patient access to medical records New Law Alert No. 11 April 2002 California edition Patient access to medical records Acupuncture treatment modalities are expanded Cervical cancer screening CME required for pain management Mental health

More information

INFO Brief. Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State

INFO Brief. Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State ADAI-IB 23-3 INFO Brief Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State O ctober 23 Caleb Banta-Green (Alcohol and Drug Abuse Institute, University of Washington),

More information

Geriatric Emergency Department Guidelines New Jersey Hospital Association, Princeton, NJ Sept. 29, 2014

Geriatric Emergency Department Guidelines New Jersey Hospital Association, Princeton, NJ Sept. 29, 2014 Geriatric Emergency Department Guidelines New Jersey Hospital Association, Princeton, NJ Sept. 29, 2014 Registration and Breakfast: 7:15 a.m. 7:45 a.m. Program Time: 7:45 a.m. 4:15 p.m. Location: NJHA

More information

HOUSE OF REPRESENTATIVES FINAL BILL ANALYSIS SUMMARY ANALYSIS

HOUSE OF REPRESENTATIVES FINAL BILL ANALYSIS SUMMARY ANALYSIS HOUSE OF REPRESENTATIVES FINAL BILL ANALYSIS BILL #: CS/CS/HB 335 FINAL HOUSE FLOOR ACTION: SPONSOR(S): COMPANION BILLS: Health & Human Services Committee; Health Quality Subcommittee; Plasencia; Campbell

More information

64th Legislature AN ACT REVISING BOARD OF NURSING LAWS; PROVIDING FOR NURSING APPLICANTS TO SUBMIT TO

64th Legislature AN ACT REVISING BOARD OF NURSING LAWS; PROVIDING FOR NURSING APPLICANTS TO SUBMIT TO 64th Legislature HB0115 AN ACT REVISING BOARD OF NURSING LAWS; PROVIDING FOR NURSING APPLICANTS TO SUBMIT TO CRIMINAL BACKGROUND CHECKS; EXPANDING THE NURSING MEDICAL ASSISTANCE PROGRAM TO ALL LICENSEES;

More information

In 2000, the passage of the Drug Addiction Treatment Act enabled. Barriers to Primary Care Physicians Prescribing Buprenorphine

In 2000, the passage of the Drug Addiction Treatment Act enabled. Barriers to Primary Care Physicians Prescribing Buprenorphine Barriers to Primary Care Physicians Prescribing Eliza Hutchinson, BA Mary Catlin, BSN, MPH C. Holly A. Andrilla, MS Laura-Mae Baldwin, MD, MPH Roger A. Rosenblatt, MD, MPH, MFR University of Washington,

More information

State Policies and Adoption of Buprenorphine: Summary Results of Telephone Interviews with State Agency Staff

State Policies and Adoption of Buprenorphine: Summary Results of Telephone Interviews with State Agency Staff State Policies and Adoption of Buprenorphine: Summary Results of Telephone Interviews with State Agency Staff Funding Source: Grant No. 053773 Robert Wood Johnson Foundation Substance Abuse Policy Research

More information

Kansas State Board of Nursing Landon State Office Building, Room 106 APRN Committee Minutes June 12, 2012

Kansas State Board of Nursing Landon State Office Building, Room 106 APRN Committee Minutes June 12, 2012 Kansas State Board of Nursing Landon State Office Building, Room 106 APRN Committee Minutes June 12, 2012 Time: Committee Members: 1:30 p.m. 2:30 p.m. Jane Symmonds, RN, MS NP-C, APRN, Chair Serena Stutzman,

More information

BOARD OF MEDICINE: 2009 SCOPE OF PRACTICE: A COMPARISON OF FLORIDA HEALTHCARE PRACTITIONERS

BOARD OF MEDICINE: 2009 SCOPE OF PRACTICE: A COMPARISON OF FLORIDA HEALTHCARE PRACTITIONERS BOARD OF MEDICINE: 2009 SCOPE OF PRACTICE: A COMPARISON OF FLORIDA HEALTHCARE PRACTITIONERS Anesthesiologist Assistant Medicine - Medical Doctor Medicine - House Physician PROFESSIONS Anesthesiologist

More information

Prescriptive Authority FAQ: Washington CRNAs

Prescriptive Authority FAQ: Washington CRNAs : Washington CRNAs This FAQ (Frequently Asked Questions) is maintained by. If you have comments or a question that is not answered here, please send it to wana1@comcast.net. DISCLAIMER: Please remember,

More information

Training in SBIRT in Medical Schools in the United States:

Training in SBIRT in Medical Schools in the United States: Training in SBIRT in Medical Schools in the United States: An Examination of Physician Education and Training on Conducting Screenings, Brief Interventions, and Referrals to Treatment Manu Singh, Ph.D.,

More information

12 TH ALL-OHIO INSTITUTE ON COMMUNITY PSYCHIATRY

12 TH ALL-OHIO INSTITUTE ON COMMUNITY PSYCHIATRY 12 TH ALL-OHIO INSTITUTE ON COMMUNITY PSYCHIATRY INTEGRATING CARE: PREPARING YOUR WORKFORCE FOR THE FUTURE MARCH 27 28, 2015 DoubleTree by Hilton Cleveland East Beachwood 3663 Park East Drive, Beachwood,

More information

Subject: Health; food and drugs; treatment of opiate addiction. Statement of purpose: This bill proposes to require the department 6of health to

Subject: Health; food and drugs; treatment of opiate addiction. Statement of purpose: This bill proposes to require the department 6of health to 2012 Page 1 of 8 1 2 3 4 5 H.627 Introduced by Representative Pugh of South Burlington Referred to Committee on Date: Subject: Health; food and drugs; treatment of opiate addiction Statement of purpose:

More information

Minimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:

Minimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment: Minimum Insurance Benefits for Patients with Opioid Use Disorder By David Kan, MD and Tauheed Zaman, MD Adopted by the California Society of Addiction Medicine Committee on Opioids and the California Society

More information

Essentials for the Spine Care Clinician

Essentials for the Spine Care Clinician Essentials for the Spine Care Clinician Saturday, November 7, 2015 Overview Primary care physicians, rheumatologists and chiropractors are commonly the first providers of spine care to patients experiencing

More information

CHAPTER 27 THE SCOPE OF PROFESSIONAL NURSING PRACTICE AND ARNP AND CNM PROTOCOLS

CHAPTER 27 THE SCOPE OF PROFESSIONAL NURSING PRACTICE AND ARNP AND CNM PROTOCOLS I. INTRODUCTION CHAPTER 27 THE SCOPE OF PROFESSIONAL NURSING PRACTICE AND ARNP AND CNM PROTOCOLS Advance registered nurse practitioners (ARNPs) and clinical nurse practitioners (CNPs) have their scope

More information

New Jersey Action Coalition (NJAC) Seamless Academic Progression Summit II New Jersey Hospital Association, Princeton, NJ. Nov.

New Jersey Action Coalition (NJAC) Seamless Academic Progression Summit II New Jersey Hospital Association, Princeton, NJ. Nov. New Jersey Action Coalition (NJAC) Seamless Academic Progression Summit II New Jersey Hospital Association, Princeton, NJ Nov. 25, 2014 Registration and Breakfast: 8:30 a.m. 9:00 a.m. Program Time: 9:00

More information

Curriculum Vitae Lawrence B. Erlich, M.D.

Curriculum Vitae Lawrence B. Erlich, M.D. Curriculum Vitae Lawrence B. Erlich, M.D. CERTIFICATIONS: Lawrence B. Erlich, M.D. 1530 Celebration Blvd. Suite 406 Celebration, Florida 34747 (407) 852-8882 (407) 830-5252 1974 -!American Board of Psychiatry

More information

Professional Education Summit Emerging Trends in Diabetes Care Saturday, October 17, 2015 9:00 am 4:00 pm* EvergreenHealth Medical Center Kirkland, WA

Professional Education Summit Emerging Trends in Diabetes Care Saturday, October 17, 2015 9:00 am 4:00 pm* EvergreenHealth Medical Center Kirkland, WA Professional Education Summit Emerging Trends in Diabetes Care Saturday, October 17, 2015 9:00 am 4:00 pm* EvergreenHealth Medical Center Kirkland, WA Register online: professional.diabetes.org/washington

More information

The University of Oklahoma School of Community Medicine, Tulsa, OK Master of Health Science in Physician Assistant Studies, 12/2011

The University of Oklahoma School of Community Medicine, Tulsa, OK Master of Health Science in Physician Assistant Studies, 12/2011 John Robert Anglin, BS, BSN, MHS, PA-C EDUCATION & TRAINING: The University of Oklahoma School of Community Medicine, Tulsa, OK Master of Health Science in Physician Assistant Studies, 12/2011 The University

More information

American Society of Addiction Medicine

American Society of Addiction Medicine American Society of Addiction Medicine Public Policy Statement on Office-based Opioid Agonist Treatment (OBOT) BACKGROUND Methadone maintenance treatment of opioid addiction was developed in 1965 and implemented

More information

Prescriber Behavior, Pain Treatment and Addiction Treatment

Prescriber Behavior, Pain Treatment and Addiction Treatment Prescriber Behavior, Pain Treatment and Addiction Treatment Mary Fleming, M.S. Director, Office of Policy, Planning, and Innovation Substance Abuse and Mental Health Services Administration NGA Policy

More information

Federal Regulations For Prescribing Scheduled Controlled Substances

Federal Regulations For Prescribing Scheduled Controlled Substances Federal Regulations For Prescribing Scheduled Controlled Substances HEIT TEMPLATE.PPT 1 Central Principle of Balance With the Use of Controlled Substances Dual imperative of government Establish a system

More information

Buprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) Risk Evaluation and Mitigation Strategy (REMS)

Buprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) Risk Evaluation and Mitigation Strategy (REMS) Initial REMS approval: 02/2013 Most recent modification: 06/2015 Buprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) Risk Evaluation and Mitigation Strategy (REMS) This REMS applies

More information

The Serenity to Integrate, the Courage not to, and the Wisdom to Know the Difference

The Serenity to Integrate, the Courage not to, and the Wisdom to Know the Difference 10 th Annual Best Practices Conference Mental Health and Addiction Treatment: The Serenity to Integrate, the Courage not to, and the Wisdom to Know the Difference Date: Thursday, April 7, 2016 Time: Place:

More information

02- DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION. Chapter 8 REGULATIONS RELATING TO ADVANCED PRACTICE REGISTERED NURSING

02- DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION. Chapter 8 REGULATIONS RELATING TO ADVANCED PRACTICE REGISTERED NURSING 02- DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION 380 BOARD OF NURSING Chapter 8 REGULATIONS RELATING TO ADVANCED PRACTICE REGISTERED NURSING SUMMARY: This chapter identifies the role of a registered

More information

Safe Passage to Superior Practice: Highlighting Legal, Ethical & Risk Management Best Practices for Florida Physicians

Safe Passage to Superior Practice: Highlighting Legal, Ethical & Risk Management Best Practices for Florida Physicians ITINERARY CME Cruise to Alaska On board Holland America s The Amsterdam CALL CONTINUING EDUCATION, INC. AT 800.422.0711 TO BOOK OR ASK QUESTIONS Sunday, August 9 th Seattle, Washington, US Embarkation

More information

Addictions 2015. Treatment Comorbidities Complex Cases

Addictions 2015. Treatment Comorbidities Complex Cases Addictions 2015 Treatment Comorbidities Complex Cases May 29 30, 2015 Cambridge, MA For Physicians, Addiction Specialists, Mental Health Professionals, Nurses, Nurse Practitioners & Social Workers Strategies,

More information

Summit Spotlight: In This Issue: Last chance for registration discount to Summit. Federal officials to open Summit Tuesday morning

Summit Spotlight: In This Issue: Last chance for registration discount to Summit. Federal officials to open Summit Tuesday morning Volume 5, Issue 23, February 25, 2016 The largest national collaboration for those impacted by Rx drug abuse & heroin use. In This Issue: * Governors devise bipartisan effort to reduce opioid abuse * Addiction

More information

BUPRENORPHINE TREATMENT

BUPRENORPHINE TREATMENT BUPRENORPHINE TREATMENT Curriculum Infusion Package (CIP) Based on the Work of Dr. Thomas Freese of the Pacific Southwest ATTC Drug Addiction Treatment Act of 2000 (DATA 2000) Developed by Mountain West

More information

Pain BC Conference: The Evolution of Pain Management October 19-20, 2012 Metrotown Hilton Hotel, Burnaby, BC

Pain BC Conference: The Evolution of Pain Management October 19-20, 2012 Metrotown Hilton Hotel, Burnaby, BC Pain BC Conference: The Evolution of Pain Management October 19-20, 2012 Metrotown Hilton Hotel, Burnaby, BC Join us for interactive, practical and evidence-based pain management education for the front

More information

The Collaborative Models of Mental Health Care for Older Iowans. Model Administration. Collaborative Models of Mental Health Care for Older Iowans 97

The Collaborative Models of Mental Health Care for Older Iowans. Model Administration. Collaborative Models of Mental Health Care for Older Iowans 97 6 The Collaborative Models of Mental Health Care for Older Iowans Model Administration Collaborative Models of Mental Health Care for Older Iowans 97 Collaborative Models of Mental Health Care for Older

More information

Physician Information. Answers to Frequently Asked Questions

Physician Information. Answers to Frequently Asked Questions Page 31 Physician Information Answers to Frequently Asked Questions Who is qualified to prescribe SUBOXONE or SUBUTEX? Physicians who: Meet one or more of the following training requirements Hold a subspecialty

More information

MEDICAL POLICY SUBJECT: OPIOID ADDICTION TREATMENT. POLICY NUMBER: 3.01.04 CATEGORY: Behavioral Health

MEDICAL POLICY SUBJECT: OPIOID ADDICTION TREATMENT. POLICY NUMBER: 3.01.04 CATEGORY: Behavioral Health MEDICAL POLICY SUBJECT: OPIOID ADDICTION TREATMENT PAGE: 1 OF: 6 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical

More information

Summer Seminar in Health Care Ethics

Summer Seminar in Health Care Ethics 28 th Annual Summer Seminar in Health Care Ethics August 3-7, 2015 University of Washington Campus Health Sciences Building T-439 Seattle, WA Sponsored by the University of Washington School of Medicine

More information

Summer Seminar in Health Care Ethics

Summer Seminar in Health Care Ethics 29 th Annual Summer Seminar in Health Care Ethics August 1-5, 2016 University of Washington Campus Health Sciences Building T-439 Seattle, WA Sponsored by the University of Washington School of Medicine

More information

Financing integrated Healthcare in Washington

Financing integrated Healthcare in Washington Financing integrated Healthcare in Washington as of: April 23. 2012 E & M Codes CPT Code 99201-99205 99211-99215 Est. Pt Diagnostic Code May be used only with physical Federally Qualified Health Centers

More information

Target Audience VHA/DoD physicians, nurses, pharmacists, and dieticians involved in the care of patients with chronic kidney disease.

Target Audience VHA/DoD physicians, nurses, pharmacists, and dieticians involved in the care of patients with chronic kidney disease. here Veterans Health Administration Employee Education System VACO Office of Quality and Safety, Evidenced Based Practice Department of Defense TRICARE Management Activity U.S. Army Medical Command, Evidence-Based

More information

Practice Protocol. Buprenorphine Guidance Protocol

Practice Protocol. Buprenorphine Guidance Protocol Practice Protocol Buprenorphine Guidance Protocol Developed by the Arizona Department of Health Services Division of Behavioral Health Services Effective Date: 02/23/11 Title Buprenorphine Guidance Protocol

More information

Nurse Practitioner Frequently Asked Questions

Nurse Practitioner Frequently Asked Questions HEALTH SERVICES Nurse Practitioner Frequently Asked Questions The Frequently Asked Questions (FAQs) have been designed to increase awareness and understanding of the Nurse Practitioner role within the

More information

Information for Pharmacists

Information for Pharmacists Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl

More information

PA CME Requirements. Alaska Alaska Physician Assistants must maintain an active NCCPA certification for license renewal.

PA CME Requirements. Alaska Alaska Physician Assistants must maintain an active NCCPA certification for license renewal. PA CME Requirements Alabama Alabama Physician Assistants must complete 25 hours of AMA PRA Category 1 or equivalent (AOA, AAFP, ACOG) CME every year for annual license renewal. If the licensee does not

More information

Request for Information: Opioid Analgesic Prescriber Education and Training Opportunities to Prevent Opioid Overdose and Opioid Use Disorder

Request for Information: Opioid Analgesic Prescriber Education and Training Opportunities to Prevent Opioid Overdose and Opioid Use Disorder This document is scheduled to be published in the Federal Register on 07/08/2016 and available online at http://federalregister.gov/a/2016-16067, and on FDsys.gov DEPARTMENT OF HEALTH AND HUMAN SERVICES

More information

The Determinations Report: A Report On the Physician Waiver Program Established by the. Drug Addiction Treatment Act of 2000 ( DATA )

The Determinations Report: A Report On the Physician Waiver Program Established by the. Drug Addiction Treatment Act of 2000 ( DATA ) The Determinations Report: A Report On the Physician Waiver Program Established by the Drug Addiction Treatment Act of 2000 ( DATA ) Submitted by the Center for Substance Abuse Treatment, Substance Abuse

More information

BUPRENORPHINE TREATMENT

BUPRENORPHINE TREATMENT BUPRENORPHINE TREATMENT Curriculum Infusion Package (CIP) Based on the Work of Dr. Thomas Freese of the Pacific Southwest ATTC Drug Addiction Treatment Act of 2000 (DATA 2000) Developed by Mountain West

More information

S. ll. To provide access to medication-assisted therapy, and for other purposes. IN THE SENATE OF THE UNITED STATES A BILL

S. ll. To provide access to medication-assisted therapy, and for other purposes. IN THE SENATE OF THE UNITED STATES A BILL ALB TH CONGRESS D SESSION S. ll To provide access to medication-assisted therapy, and for other purposes. IN THE SENATE OF THE UNITED STATES llllllllll Mr. MARKEY (for himself, Mrs. FEINSTEIN, Mr. ROCKEFELLER,

More information

Treatment Programs (OMTP)

Treatment Programs (OMTP) Sponsored by: Continuing Medical Education Program best practices for Opiate Maintenance Treatment Programs (OMTP) Avoid Abuse, Limit Liability May 8-11, 2012 December 4-7, 2012 Case Western Reserve University

More information

NP CE Requirements. California California Nurse Practitioners must complete 30 hours of continuing nursing education every two years.

NP CE Requirements. California California Nurse Practitioners must complete 30 hours of continuing nursing education every two years. NP CE Requirements Alabama Nurse practitioners will renew their license every two years. They must complete 24 hours of Board-approved continuing education. If they have prescriptive authority, 6 of the

More information

Guidelines for State Regulation of Physician Assistants (Adopted 1988, amended 1993, 1998, 2001, 2005, 2006, 2009, and 2011)

Guidelines for State Regulation of Physician Assistants (Adopted 1988, amended 1993, 1998, 2001, 2005, 2006, 2009, and 2011) (Adopted 1988, amended 1993, 1998, 2001, 2005, 2006, 2009, and 2011) Executive Summary of Policy Contained in this Paper Summaries will lack rationale and background information, and may lose nuance of

More information

1) ELIGIBLE DISCIPLINES

1) ELIGIBLE DISCIPLINES PRACTITIONER S APPLICABLE TO ALL INDIVIDUAL NETWORK PARTICIPANTS AND APPLICANTS FOR THE PREFERRED PAYMENT PLAN NETWORK, MEDI-PAK ADVANTAGE PFFS NETWORK AND MEDI-PAK ADVANTAGE LPPO NETWORK. 1) ELIGIBLE

More information

The Eighteenth Annual Tennessee Workers Compensation Educational Conference

The Eighteenth Annual Tennessee Workers Compensation Educational Conference The Eighteenth Annual Sponsored By The Tennessee Division of Workers Compensation Nashville Airport Marriott In association with the International Workers Compensation Foundation, a non-profit corporation

More information

King County Drug Trends 2015

King County Drug Trends 2015 Brad Finegood, MA, LMHC Assistant Division Director, Acting RSN Administrator Prevention and Treatment Coordinator King County Behavioral Health and Recovery Division Caleb Banta-Green PhD, MPH, MSW Senior

More information

Guide to CE Navigation and Frequently Asked Questions (FAQs)

Guide to CE Navigation and Frequently Asked Questions (FAQs) Guide to CE Navigation and Frequently Asked Questions (FAQs) Guide to CE Navigation CE credit preferences, method of participation and credit designations, disclosures and requirements for eligibility,

More information

21st Annual OSF Cardiovascular Symposium

21st Annual OSF Cardiovascular Symposium 21st Annual OSF Cardiovascular Symposium new waves in cardiac electrophysiology saturday 18 october 2014 7:00 a.m. 4:00 p.m. embassy suites conference center east peoria, illinois OBJECTIVES Overall Program:

More information

CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. Las Vegas, Nevada Bellagio March 4 6, 2016. Participating Faculty

CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. Las Vegas, Nevada Bellagio March 4 6, 2016. Participating Faculty CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE Las Vegas, Nevada Bellagio March 4 6, 2016 Participating Faculty Friday, March 4th: 7:30 am - 8:00 am Registration and Hot Breakfast 8:00 am - 9:00 am Pulmonary

More information

Subject: Health; food and drugs; treatment of opiate addiction. Statement of purpose: This bill proposes to require the department 6of health to

Subject: Health; food and drugs; treatment of opiate addiction. Statement of purpose: This bill proposes to require the department 6of health to 2012 Page 1 of 6 1 2 3 4 5 H.627 Introduced by Representative Pugh of South Burlington Referred to Committee on Date: Subject: Health; food and drugs; treatment of opiate addiction Statement of purpose:

More information

Defining Scope of Practice for Nurse Practitioners: A Regulatory Perspective

Defining Scope of Practice for Nurse Practitioners: A Regulatory Perspective Defining Scope of Practice for Nurse Practitioners: A Regulatory Perspective Tracy Klein, MS, WHCNP,FNP Advanced Practice Consultant Oregon State Board of Nursing September 2006 Who determines your scope

More information

INSTRUCTIONS for PRESCRIPTIVE AUTHORITY RECOGNITION for the ADVANCED PRACTICE REGISTERED NURSE

INSTRUCTIONS for PRESCRIPTIVE AUTHORITY RECOGNITION for the ADVANCED PRACTICE REGISTERED NURSE Oklahoma Board of Nursing 2915 N. Classen Boulevard, Suite 524 Oklahoma City, OK 73106 (405) 962-1800 www.ok.gov/nursing INSTRUCTIONS for PRESCRIPTIVE AUTHORITY RECOGNITION for the ADVANCED PRACTICE REGISTERED

More information

CHAPTER ONE GENERAL PROVISIONS

CHAPTER ONE GENERAL PROVISIONS CHAPTER ONE GENERAL PROVISIONS SECTION I PURPOSE AND AUTHORITY A. PURPOSE 1. ARKANSAS NURSE PRACTICE ACT - Requires that any person who practices or offers to practice professional nursing, advanced practice

More information

Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy

Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy Category: Heroin Title: Methadone Maintenance vs 180-Day psychosocially Enriched Detoxification for Treatment of Opioid Dependence: A Randomized Controlled Trial Authors: Karen L. Sees, DO, Kevin L. Delucchi,

More information

To register to attend this event, please visit www.aahivm.org/events/exec/events.

To register to attend this event, please visit www.aahivm.org/events/exec/events. HIV Care Under the Affordable Care Act: Addressing the Needs of HIV Providers & Health Professionals In Arizona A policy training event with CME/CE credit available for MDs, DOs, PAs, NPs, RNs, Pharm Ds,

More information

Professional Criteria and Medicaid Reimbursable Outpatient Services by Professionals

Professional Criteria and Medicaid Reimbursable Outpatient Services by Professionals Professional Criteria and Medicaid Reimbursable Outpatient Services by Professionals The purpose of this document is to clarify who can provide which outpatient services to Iowa Plan Medicaid members.

More information

Frequently Asked Questions For Emergency Part 828 Opioid Treatment Program Regulations

Frequently Asked Questions For Emergency Part 828 Opioid Treatment Program Regulations Frequently Asked Questions For Emergency Part 828 Opioid Treatment Program Regulations Effective Monday February 8, 2010 OASAS adopted the new NYS OASAS Part 828 Opioid Treatment Program regulations. Since

More information

Best Practices in Opioid Dependence Treatment

Best Practices in Opioid Dependence Treatment Best Practices in Opioid Dependence Treatment Anthony L. Jordan Health Center Linda Clark, MD, MS Medical Director Alana Ramos, BS Suboxone Clinic Manager Case Studies Nicole White female 27 years of age

More information

SAMHSA Initiatives to Educate Prescribers and Consumers and Treatment Resources

SAMHSA Initiatives to Educate Prescribers and Consumers and Treatment Resources SAMHSA Initiatives to Educate Prescribers and Consumers and Treatment Resources Nick Reuter Division of Pharmacologic Therapy Substance Abuse and Mental Health Services Administration 1 Overview National

More information

Nuclear Medicine Residency Program. University of Washington School of Medicine Department of Radiology Seattle, Washington

Nuclear Medicine Residency Program. University of Washington School of Medicine Department of Radiology Seattle, Washington Nuclear Medicine Residency Program University of Washington School of Medicine Department of Radiology Seattle, Washington Updated: July 2015 1 Introduction The Nuclear Medicine Division at the University

More information

SUBOXONE /VIVITROL WEBINAR. Educational Training tool concerning the Non-Methadone Medication Assisted Treatment Policy that is Effective on 1/1/12

SUBOXONE /VIVITROL WEBINAR. Educational Training tool concerning the Non-Methadone Medication Assisted Treatment Policy that is Effective on 1/1/12 SUBOXONE /VIVITROL WEBINAR Educational Training tool concerning the Non-Methadone Medication Assisted Treatment Policy that is Effective on 1/1/12 WEBINAR INTRODUCTIONS Cynthia Parsons- Program Manager

More information

CURRICULUM VITAE. Veterans Administration Medical Center, Psychiatry Service 1984-1986 San Francisco, CA Fellow in Substance Use Disorders

CURRICULUM VITAE. Veterans Administration Medical Center, Psychiatry Service 1984-1986 San Francisco, CA Fellow in Substance Use Disorders CURRICULUM VITAE H. Westley Clark, M.D., J.D., M.P.H., CAS, FASAM Director, Center for Substance Abuse Treatment Substance Abuse and Mental Health Services Administration Department of Health & Human Services

More information

Medication Assisted Treatment for Opioid Use Disorders. AGENCY: Substance Abuse and Mental Health Services Administration (SAMHSA),

Medication Assisted Treatment for Opioid Use Disorders. AGENCY: Substance Abuse and Mental Health Services Administration (SAMHSA), This document is scheduled to be published in the Federal Register on 07/08/2016 and available online at http://federalregister.gov/a/2016-16120, and on FDsys.gov DEPARTMENT OF HEALTH AND HUMAN SERVICES

More information